Clinical Trials for Secondary hyperparathyroidism
Clinical trials are research studies conducted in an effort to improve overall patient health and care.
Each trial involves running supervised tests to determine the effectiveness and safety of new drugs, procedures and/or devices with the aim of answering scientific questions about a disease or condition.
Risks and side-effects are also evaluated during these trials with results ranging from being unpleasant, with side effects such as headaches, to more serious or even life-threatening risks.
A clinical trial may be separated into phases, or steps, with each step designed to answer a separate research question. This maybe reflected in the trial name.
A brief description of each phase:
- Phase I: Usually designed to evaluate safety, determine a safe dosage range, and identify side effects on a small group of patients.
- Phase II: If Phase I is successful, the trial is then repeated with a larger group to further evaluate its effect and safety.
- Phase III: Trials are conducted on an ever larger group and are compared with the best current treatment while gathering more information on effect and safety.
- Phase IV: These studies monitor long-term side effects after the treatment has been marketed.
Clinical Trials data for Secondary hyperparathyroidism is grouped into the following categories:-
The format for each of the following is:
- The name of the trial,
- followed by whether the trial is recruiting patients,
- The trial may not have started and not yet recruiting, or the trial may have started and do not need any more recruitements, or the trial may be completed.
- Note**: Please follow the link to determine the current trial status.
- followed by a list of drug/s, if any, used in the trial
ClinicalTrials.gov has listed the following trials for Secondary hyperparathyroidism:
- Study to Evaluate the Effects of Zemplar Injection and Calcijex on Intestinal Absorption of Calcium - This study has been completed (Current: 23 Nov 2006) - Zemplar,Calcijex
- START: Sensipar Treatment Algorithm to Reach K/DOQI Targets in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism - This study is no longer recruiting patients (Current: 23 Nov 2006) - Sensipar
- Characterization of Hyperparathyroidism and Vitamin D Deficiency in Obesity - This study is currently recruiting patients (Current: 23 Nov 2006) - Ergocalciferol,Cholecalciferol
- Calcium and Vitamin D Malnutrition in Elderly Women - This study is no longer recruiting patients (Current: 23 Nov 2006)
- SENSOR: Study to Investigate Cinacalcet Treatment in Haemodialysis Patients With Secondary Hyperparathyroidism - This study is no longer recruiting patients (Current: 23 Nov 2006) - cinacalcet
- E.V.O.L.V.E. Trial: EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events - This study is currently recruiting patients (Current: 23 Nov 2006) - Sensipar (Cinacalcet HCl)
- Initial Dosing of Paricalcitol in Secondary Hyperparathyroidism - This study has been completed (Current: 23 Nov 2006) - paricalcitol
- CARE-2 (Calcium Acetate [PhosLo]/Sevelamer[Renagel] Evaluation Study 2) for Heart Calcification in Dialysis Patients - This study is currently recruiting patients (Current: 23 Nov 2006) - PhosLo (calcium acetate)
- Evaluation of Colecalciferol Substitution in Dialysis Patients - This study is currently recruiting patients (Current: 23 Nov 2006) - Colecalciferol
- Acute Regulation of Parathyroid Hormone by Dietary Phosphate - This study has been completed (Current: 23 Nov 2006)
- A Study of an Investigational Medication for the Treatment of Secondary Hyperparathyroidism in Dialysis Patients - This study has been completed (Current: 23 Nov 2006) - AMG 073
- A Study of an Investigational Medication for Secondary Hyperparathyroidism in Chronic Renal Insufficiency Patients - This study is no longer recruiting patients (Current: 23 Nov 2006) - AMG 073
- A Study of an Investigational Medication for the Treatment of Secondary Hyperparathyroidism in Patients on Dialysis - This study is no longer recruiting patients (Current: 23 Nov 2006) - AMG 073
- Safety and Effectiveness of Zemplar Injection in Decreasing iPTH Levels in Pediatric ESRD Subjects on Hemodialysis - This study has been completed (Current: 23 Nov 2006) - paricalcitol injection
- Study of Safety and Efficacy of Doxercalciferol in Patients With Chronic Kidney Disease, Stage 3 or 4, and Secondary Hyperparathyroidism - This study is currently recruiting patients (Current: 23 Nov 2006) - Doxercalciferol, 0.5mcg
- ACHIEVE: Optimizing the Treatment of Secondary Hyperparathyroidism - This study is currently recruiting patients (Current: 23 Nov 2006) - Sensipar®
- The Efficacy of 1,25 Dihydroxycholecalciferol on the Cardiovascular System in Patients With Renal Dysfunction - This study is currently recruiting patients (Current: 23 Nov 2006) - 1.25 dihydroxycholecalciferol
- A Study to Evaluate the Effects of Two Vitamin D Analogs, Zemplar Injection and Hectorol Injection, on Intestinal Absorption of Calcium in Patients With Stage 5 Chronic Kidney Disease - This study is currently recruiting patients (Current: 23 Nov 2006) - Zemplar® Injection,Hectorol® Injection
- Bone Biopsy Study For Dialysis Patients With Secondary Hyperparathyroidism of End Stage Renal Disease - This study is currently recruiting patients (Current: 23 Nov 2006) - Sensipar (Cinacalcet HCl)
- ADVANCE: Study to Evaluate Cinacalcet Plus Low Dose Vitamin D on Vascular Calcification in Subjects With Chronic Kidney Disease Receiving Hemodialysis - This study is not yet open for patient recruitment (Current: 23 Nov 2006) - cinacalcet
- Post Transplant Study - This study has been completed (Current: 23 Nov 2006) - Sensipar after Post Transplant
- Comparison of Cholecalciferol Versus Doxercalciferol in the Treatment of Secondary Hyperparathyroidism in Chronic Kidney Disease Stage Three and Four - This study is currently recruiting patients (Current: 23 Nov 2006) - doxercalciferol and cholecalciferol
- Phase II Randomized Study of the Effects of Growth Hormone on Children and Adolescents on Maintenance Dialysis - This study has been completed (Current: 23 Nov 2006) - calcitriol,growth hormone
- Osteopenia and Renal Osteodystrophy: Evaluation and Management - This study is no longer recruiting patients (Current: 23 Nov 2006) - pamidronate
- Klotho Gene Polymorphism in Dialyzed Patients With Hyperphosphatemia - This study is currently recruiting patients (Current: 23 Nov 2006)
- Research Study Evaluating Cinacalcet for Patients With End Stage Renal Disease (ESRD) - This study has been completed (Current: 23 Nov 2006) - Cinacalcet
- A Multi-Center, Observational Registry of Subjects With Secondary Hyperparathyroidism (HPT) and Chronic Kidney Disease (CKD) - This study is currently recruiting patients (Current: 23 Nov 2006) - Sensipar®
- A Research Study for Patients With End-Stage Renal Disease (ESRD) - This study is no longer recruiting patients (Current: 23 Nov 2006) - cinacalcet
- Cinacalcet Study to Reach Kidney Disease Outcomes Quality Initiative (K/DOQI) Levels - This study has been completed (Current: 23 Nov 2006) - Cinacalcet
The format for each of the following is:
- The drug,
- followed by the name of the trial,
- followed by whether the trial is recruiting patients,
- The trial may not have started and not yet recruiting, or the trial may have started and do not need any more recruitements, or the trial may be completed.
- Note**: Please follow the link to determine the current trial status.
ClinicalTrials.gov has listed the following drugs in trials for Secondary hyperparathyroidism:
The trial data on this page has been sourced from
